Business Wire

MA-ECHOSENS

11.11.2021 14:55:11 CET | Business Wire | Press release

Share
Echosens Presents Research at 2021 AASLD Liver Meeting: Early Detection and Monitoring with FibroScan Mitigates Risk of Patients Developing Fibrosis/Cirrhosis

Echosens , a high-technology company offering the FibroScan® family of products, is pleased to announce its strong presence at the upcoming American Association for the Study of Liver Diseases (AASLD) Liver Meeting , a digital conference, Nov. 12-15, 2021, with FibroScan-based solutions - referenced in 19 oral presentations and 180 poster presentations. They include new results demonstrating the clinical usefulness of liver and spleen stiffness measurement by VCTE as well as CAP but also further confirm the performances of Fast™, Agile 3+, Agile 4 and FibroMeter VCTE scores in many different settings.

“Non-invasive FibroScan is an innovative technology that advances efforts to halt the progression of fatty liver disease (FLD) and empowers healthcare providers with an accurate, point-of-care tool to measure liver fat and stiffness,” says Dominique Legros, Group CEO, Echosens. “Our technology solutions serve as the cornerstone of non-invasive tests for the future of liver disease management—across the liver care continuum and all population groups. With better assessment tools in primary care, unnecessary specialist referrals and more invasive and expensive diagnostic testing can be reduced.”

FLD includes nonalcoholic fatty liver disease (NAFLD), the accumulation of liver fat in people who drink little or no alcohol, and its more severe form nonalcoholic steatohepatitis (NASH).

NAFLD is often present as a comorbidity in patients with Type 2 diabetes. The mutual interrelationship between these conditions shows that Type 2 diabetes can exacerbate NAFLD by promoting progression to NASH, often leading to fibrosis and cirrhosis, while NAFLD causes the natural course of diabetic complications to worsen in Type 2 diabetes patients .

NAFLD affects about 25% of people in the world. As the rates of obesity, Type 2 diabetes and high cholesterol rise, so does the rate of NAFLD. FibroScan is acknowledged worldwide and validated by over 3,000 peer reviewed publications and 140 international guidelines across 100+ countries.

Jon Gingrich, CEO, Echosens North America, says, “This important conference allows us to showcase FibroScan as a valuable innovation that can improve care and reduce costs for managing chronic liver conditions. The expanding body of data supports FibroScan as an early assessment and monitoring tool that can mitigate the risk that patients will develop more serious conditions like fibrosis, cirrhosis and liver cancer.”

About Echosens
Pioneer in its field, Echosens significantly changed the practice of liver assessment with FibroScan®, the non-invasive solution for comprehensive management of liver health. FibroScan® is recognized worldwide and validated by over 3,000 peer reviewed publications and 140 international guidelines. Echosens has made FibroScan® available in over 100+ countries enabling millions of liver examinations worldwide. https://www.echosens.com/

Link:

ClickThru

Social Media:

https://www.facebook.com/fibroscan.echosens

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Sytel Reply Named Zuora’s 2025 EMEA RSI Partner of the Year Enabling Value-Based Monetization for AI24.3.2026 13:21:00 CET | Press release

Sytel Reply, the Reply Group company specialized in subscription management, billing transformation and revenue management platforms, has been recognized by Zuora as its 2025 EMEA RSI Partner of the Year for its expertise in Zuora implementation and strategic consulting in monetization across the EMEA region. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260324359888/en/ By combining deep platform expertise, revenue model design capabilities and advanced AI solutions, Sytel Reply and Revise Reply position themselves as strategic partners for organizations seeking to evolve their business models and transform AI adoption into tangible and sustainable economic value. The recognition highlights more than a decade of experience on the Zuora platform and a dedicated center of excellence comprising certified specialists in subscription management, revenue recognition, billing optimization and financial analytics. Sytel Reply supp

Klarna and Elliott Deepen Partnership With $2bn Facility Supporting $17bn of US Financing Expansion24.3.2026 13:07:00 CET | Press release

Klarna, the global digital bank and flexible payments provider, today doubled its existing forward-flow and whole-loan sale agreement with investment funds managed by Elliott Investment Management. The facility size doubles to $2bn and the term extends by one year to three years, enabling Klarna to facilitate up to $17bn-worth of US Financing loans during the remaining life of the program. "Klarna's US Financing is growing fast because it gives Americans something the credit card industry never has: real choice, clear terms, and no surprises. This partnership sets the foundation for us to meet the accelerating demands of our American consumers." — Niclas Neglen, Chief Financial Officer, Klarna The upsizing reflects the strong performance of the program since the two companies first announced their partnership in November 2025. In Q4 2025, Klarna's US Financing GMV grew significantly, and the expanded facility gives Klarna further capacity to support the accelerated demand. Under the ag

NetApp and Elastio Announce Partnership to Deliver Defense-in-Depth Ransomware Resilience24.3.2026 13:00:00 CET | Press release

Robust cyber resilience requires both perimeter defenses and built-in security at the storage layer NetApp® (NASDAQ: NTAP), the Intelligent Data Infrastructure company, and Elastio are helping enterprises enhance their cyber resilience with a layered defense that extends from production storage into recovery data. Security teams must be ready to address threats at every layer of their technology stack, including ransomware that moved quietly through production before it was caught that now lives inside snapshots and backups. Advanced ransomware is engineered to evade prevention tools, moving quietly through production, staying below detection thresholds, reaching backup data before any alert is triggered. "As we migrated our infrastructure, ensuring we had the right level of backup security and assurance was non-negotiable,” Marc Crudgington, VP IT Infrastructure and CISO, Crane WW Logistics. “Elastio provided continuous inspection of our backups from day one - giving us confidence in

NetApp and Commvault Advance Cyber Resilience with Strategic Alliance24.3.2026 13:00:00 CET | Press release

Joint unified cyber resilience solution delivers data security and rapid recovery across hybrid environments NetApp® (NASDAQ: NTAP), the Intelligent Data Infrastructure company, and Commvault (NASDAQ: CVLT), a leader in unified resilience at enterprise scale, today announced a strategic alliance to deliver a powerful, integrated solution for enterprise data protection and cyber resilience. The unified solution enables resilience, security, and rapid recovery for customers across on-premises and cloud environments, giving organizations confidence that their data is always available, immutable, and recoverable. “This alliance reinforces NetApp and Commvault’s leadership in the rapidly evolving cyber resilience and data protection market,” said Dallas Olson, Chief Commercial Officer at NetApp. “Together we’re helping customers make their infrastructure intelligent and secure so they have the confidence that their data is always available, protected, and recoverable—no matter where it live

SBC Medical Announces Next-Generation Wellness Strategy “SBC Wellness 2.0”24.3.2026 13:00:00 CET | Press release

Pioneering the “Performance Medicine” category for full-scale entry into the longevity market — targeting a global market projected to reach $2 trillion by 2035 SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a Management Services Organization operating a wide range of franchise businesses across diverse medical fields, today announced “SBC Wellness 2.0,” a new wellness and longevity platform that combines aesthetic healthcare, preventative care, and data-driven health management. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260323000188/en/ SBC Medical Announces Next-Generation Wellness Strategy “SBC Wellness 2.0” The initiative positions SBC Medical to participate in the fast-growing longevity market, which is projected to reach approximately $800 billion in 2025* and expand to approximately $2 trillion by 2035, with a compound annual growth rate exceeding 10% from 2026 to 2035. Th

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye